Joanne Quan

Joanne Quan is a declared insider at 2 companies; the most frequent names are Mirum Pharmaceuticals, Inc. and Eiger BioPharmaceuticals, Inc. In total, 11 filings cover trades dated from 2 April 2018 to 16 March 2026.

The open-market record consists of 5 sales worth €1.6M, with no purchase. The rest of the record consists of 1 share grant and 5 option exercises. In 2026 alone, the filings show no purchases and 3 sales.

The latest filing, published on 17 March 2026, reports an open-market sale of €586k in Mirum Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.